U.N. official calls for moratorium on artificial intelligence tools that breach human rights
By Sammy Westfall,
The Washington Post
| 09. 15. 2021
The rapid evolution of artificial-intelligence-based technologies and their adoption by businesses and governments have outpaced efforts to hold them to human rights standards, Michelle Bachelet, the United Nations Commissioner for Human Rights, warned Wednesday.
She called for a moratorium on artificial intelligence systems that could put human rights at risk — at least until stronger safeguards are in place internationally.
“We cannot afford to continue playing catch-up regarding AI — allowing its use with limited or no boundaries or oversight, and dealing with the almost inevitable human rights consequences after the fact,” she said in a statement.
The remarks came alongside the publication of a report by the U.N. Human Rights Council analyzing the human rights risks posed by a range of AI-powered technologies — including profiling, automated decision-making and machine learning. The consequences of unfettered proliferation of such technologies could be “catastrophic,” Bachelet said.
The report also pointed out that data sets used by AI can have historical racial and ethnic biases embedded, which can perpetuate, or enhance, discrimination.
Many AI tools seek to predict outcomes, assess risk and...
Related Articles
By Lucy Tu, The Atlantic | 07.11.2025
Donald Trump—who is, by his own accounting, “the fertilization president” and “the father of IVF”—wants to help Americans reproduce. During his 2024 campaign, he promised that the government or insurance companies would cover the cost of in vitro fertilization. In...
By Jared Whitlock, Endpoints News | 07.15.2025
Patient groups face a harder and unpredictable path going state-by-state to boost screening for rare but treatable conditions after the Trump administration disbanded a federal advisory committee on newborn screening.
In April, the Advisory Committee on Heritable Disorders in Newborns...
By Ben Fidler and Ned Pagliarulo, Biopharma Dive | 07.21.2025
One month ago, a 51-year-old man treated in a clinical trial with an experimental gene therapy became dangerously sick. The developer of that treatment, Sarepta Therapeutics, informed the Food and Drug Administration his case could be life-threatening.
The man died...
By Pat Duggins, Alabama Public Radio | 06.27.2025
PAT DUGGINS-- If I were to say, ‘man, have you seen the price of eggs these days?’ You're probably thinking, Oh, he's talking about inflation and the price of groceries and how it became an issue in the presidential race...
